phenyl acetate has been researched along with kb 2115 in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Josseaume, C; Lorcy, Y | 1 |
Eller, P; Patsch, JR; Ritsch, A; Tancevski, I | 1 |
Cioffi, F; Goglia, F; Lanni, A | 1 |
Baxter, JD; Gustafsson, JÅ; Hsueh, WA; Lin, JZ; Martagón, AJ; Phillips, KJ; Webb, P | 1 |
Baxter, J; Beddow, SA; Bogan, JS; Erion, DM; Grover, GJ; Kumashiro, N; Liao, XH; Phillips, KJ; Samuel, VT; Shulman, GI; Vatner, DF; Webb, P; Weismann, D; Weiss, RE | 1 |
Cimini, SL; Lin, JZ; Martagón, AJ; Phillips, KJ; Webb, P | 1 |
Cioffi, F; Goglia, F; Lanni, A; Petito, G; Senese, R | 1 |
Zucchi, R | 1 |
4 review(s) available for phenyl acetate and kb 2115
Article | Year |
---|---|
The resurgence of thyromimetics as lipid-modifying agents.
Topics: Acetates; Anilides; Animals; Anticholesteremic Agents; Arteriosclerosis; Atherosclerosis; Biological Transport; Biomimetics; Cholesterol, LDL; Clinical Trials as Topic; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipid Metabolism; Malonates; Molecular Structure; Organophosphonates; Phenols; Phenyl Ethers; Phenylacetates; Propionates; Pyridazines; Receptors, LDL; Thyroid Gland; Thyroid Hormones | 2009 |
Thyroid hormones, mitochondrial bioenergetics and lipid handling.
Topics: Acetates; Adiposity; Anilides; Animals; Atherosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Diiodothyronines; Dyslipidemias; Energy Metabolism; Fatty Liver; Humans; Lipid Metabolism; Mice; Mitochondria; Obesity; Phenols; Rats; Thyroid Hormones | 2010 |
Thyroid hormone metabolites and analogues.
Topics: Acetates; Anilides; Animals; Diiodothyronines; Humans; Phenols; Phenyl Ethers; Phenylacetates; Propionates; Thyroid Hormones | 2019 |
Thyroid Hormone Analogues: An Update.
Topics: Acetates; Anilides; Animals; Central Nervous System Diseases; Clinical Trials as Topic; Diiodothyronines; Drug Design; Dyslipidemias; Humans; Liver Diseases; Male; Mice; Mutation; Non-alcoholic Fatty Liver Disease; Phenols; Pyridazines; Rats; Signal Transduction; Thyroid Hormone Receptors alpha; Thyroid Hormone Receptors beta; Thyroid Hormones; Thyronines; Triiodothyronine; Uracil | 2020 |
4 other study(ies) available for phenyl acetate and kb 2115
Article | Year |
---|---|
[Thyroid hormone analogs: an important biological supply and new therapeutic possibilities].
Topics: Acetates; Anilides; Anticholesteremic Agents; Humans; Hypolipidemic Agents; Phenols; Phenyl Ethers; Phenylacetates; Receptors, Thyroid Hormone; Signal Transduction; Thyroid Hormones; Triiodothyronine | 2008 |
Thyroid hormone receptor agonists reduce serum cholesterol independent of the LDL receptor.
Topics: Acetates; Anilides; Animals; Apolipoproteins B; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Feces; Lipoproteins; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phenols; Receptors, LDL; Receptors, Thyroid Hormone; Thyroid Hormone Receptors beta; Triglycerides; Triiodothyronine | 2012 |
Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways.
Topics: Acetates; Anilides; Animals; Dietary Fats; Fatty Liver; Gene Expression; Gluconeogenesis; Glucose Transporter Type 4; Hyperglycemia; Hyperinsulinism; Insulin Resistance; Male; Muscle, Skeletal; Non-alcoholic Fatty Liver Disease; Phenols; Rats; Rats, Sprague-Dawley; Signal Transduction; Thyroid Hormone Receptors beta; Triglycerides | 2013 |
The amelioration of hepatic steatosis by thyroid hormone receptor agonists is insufficient to restore insulin sensitivity in ob/ob mice.
Topics: Acetates; Anilides; Animals; Blood Glucose; Body Temperature; Dose-Response Relationship, Drug; Enzyme Induction; Glucose-6-Phosphatase; Insulin Resistance; Male; Mice; Mice, Obese; Non-alcoholic Fatty Liver Disease; Phenols; Receptors, Thyroid Hormone; Time Factors | 2015 |